In this morning’s unfolding drama, U.S. stock futures painted a rosy picture, with the Dow futures shining bright, up by around 90 points on Thursday.
A star that rose notably in today’s pre-market sky is none other than Simulations Plus, Inc. SLP, which ascended gracefully after unveiling second-quarter results that surpassed expectations.
Simulations Plus outshone predictions with adjusted earnings of 20 cents per share, surpassing market estimates. In a melodious tune, the company’s quarterly sales hit $18.300 million, outshining expectations of $17.283 million.
Adding to the crescendo, Simulations Plus shared a harmonious forecast for FY24, with anticipated earnings of 66 to 68 cents per share on revenue ranging from $66 million to $69 million.
As the sun of pre-market trading rose, Simulations Plus shares danced to an upbeat tune, soaring 8.9% to $41.88.
Joining this melodic ensemble were other stars on the pre-market stage, including:
- Destiny Tech100 Inc. DXYZ, up 14.5% to $30.95, following a spectacular 27% surge on Wednesday.
- Cronos Group Inc. CRON, rising 12.9% to $3.25 in pre-market trading after an 8% climb on Wednesday.
- MacroGenics, Inc. MGNX, climbing 11.8% to $15.28 in pre-market trading, with news about the TAMARACK study.
- Mind Medicine (MindMed) Inc. MNMD, up 10.6% to $13.00 in pre-market trading, adding to the morning serenade.
- Levi Strauss & Co. LEVI, rising 7.9% to $20.13, after a successful first quarter earnings report and optimistic 2024 guidance.
- BlackBerry Limited BB, up 7.8% to $3.03 in pre-market trading after its fourth-quarter report and FY25 guidance.
- Aurora Cannabis Inc. ACB, rising 5.4% to $7.60 in pre-market trading after a stellar performance the day before.
- Lamb Weston Holdings, Inc. LW, up 4% to $105.10 in pre-market trading, setting the stage for quarterly earnings.
For the full symphony of this market overture, explore more: Investor Optimism Improves; But Dow Falls For Third Session
Don’t forget to check out our premarket coverage here
